| |
|
|
|
AC Immune S.A.  
|
|
7.43 0.1 (0.01%) |
03-05 16:00 |
|
Open: |
7.5 |
Pre close: |
7.33 |
Target:
|
11.59
|
|
High: |
7.5 |
Low: |
7 |
Resistance:
|
9.92
12.50
|
|
Volume: |
372,426 |
Market Cap: |
533M |
Support:
|
5.75
4.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.48
 |
MACD |
MACD(12,26):
|
0.22 |
|
MA(20): |
7.76  |
Signal(12,26,9): |
0.35 |
|
MA(100): |
5.88 |
Stochastic Oscillator |
%K(14,3):
|
12.11 |
|
MA(250): |
6.51 |
%D(3): |
10.75 |
|
Average Volume(K) |
3-Month: |
101764
|
52-Week |
High:
|
13.00 |
|
10-Days: |
56515 |
Low: |
4.07 |
|
RSI |
RSI(14):
|
51.22 |
Change(%): |
25.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-23.5 |
Shares Out. (M) |
71.74 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-13.3 |
Shares Float (M) |
28.75 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.99 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
-96.6 |
% Held by Institutions |
29.82 |
|
Forward EPS |
-0.837 |
Gross Profit (p.s.) |
0.845 |
Shares Short (K) |
1230 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-13.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.48 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
